Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Clinical Trials Search Results
Search History:
Count: 51
Selected: 0
| NCT ID | Title | ||
|---|---|---|---|
| NCT05413135 | Study of ARO-APOC3 in Adults With Dyslipidemia | ||
| NCT07221344 | Study of ARO-MAPT-SC in Healthy Participants and Participants With Early Alzheimer's Disease | ||
| NCT02604199 | A Multi-dose Study of ARC-520 in Patients With Hepatitis B 'e' Antigen (HBeAg) Negative, Chronic Hepatitis B Virus (HBV) Infection | ||
| NCT07241546 | Study of Inhaled ARO-RAGE in Allergen-induced Mild Asthma | ||
| NCT07473843 | Study of Zodasiran in Adolescent Participants With Homozygous Familial Hypercholesterolemia | ||
| NCT06347016 | Study of Plozasiran in Adults With Severe Hypertriglyceridemia | ||
| NCT02065336 | A Multicenter Study to Determine the Depth and Duration of Hepatitis B Surface Antigen (HBsAg) Reduction After Single or Multiple Doses of ARC-520, in Combination With Entecavir in Patients With Chronic Hepatitis B Virus (HBV) Infection | ||
| NCT06347133 | Phase 3 Study of Plozasiran in Adults With Hypertriglyceridemia | ||
| NCT02577029 | Study of ARC-520 With or Without Other Drugs Used in the Treatment of Chronic Chronic Hepatitis B Virus (HBV) | ||
| NCT05089084 | Study of ARO-APOC3 (Plozasiran) in Adults With Familial Chylomicronemia Syndrome (FCS) | ||
| NCT02738008 | Extension Study of the Safety and Efficacy of Multi-dose Intravenous ARC-520 in Patients With Chronic Hepatitis B (HBV) Infection | ||
| NCT07662096 | A First-In-Human Study of ARO-033 in Adult Participants | ||
| NCT04832971 | Study of ARO-ANG3 in Adults With Mixed Dyslipidemia | ||
| NCT04169711 | Study of ARO-HIF2 in Patients With Advanced Clear Cell Renal Cell Carcinoma | ||
| NCT02604212 | A Multi-dose Study of ARC-520 in Patients With Hepatitis B 'e' Antigen (HBeAg) Positive, Chronic Hepatitis B Virus Infection | ||
| NCT06822790 | Long-Term Safety and Efficacy of Plozasiran in Adults With Hypertriglyceridemia | ||
| NCT03365947 | Study of ARO-HBV in Normal Adult Volunteers and Patients With Hepatitis B Virus (HBV) | ||
| NCT04720534 | Study to Evaluate ARO-APOC3 in Adults With Severe Hypertriglyceridemia | ||
| NCT05083364 | Study of ARO-C3 in Adult Healthy Volunteers and Patients With Complement Mediated Renal Disease | ||
| NCT02363946 | A Study of ARC-AAT in Healthy Volunteer Subjects and Patients With Alpha-1 Antitrypsin Deficiency (AATD) | ||
| NCT05276570 | Study of ARO-RAGE in Healthy Subjects and Patients With Inflammatory Lung Disease | ||
| NCT05533294 | Study of ARO-RAGE in Healthy Subjects | ||
| NCT04202354 | Study of ARO-HSD in Healthy Volunteers and Patients With Non-Alcoholic Steatohepatitis (NASH) or Suspected NASH | ||
| NCT04998201 | Study of Plozasiran (ARO-APOC3) in Adults With Mixed Dyslipidemia | ||
| NCT05292950 | Study of ARO-MUC5AC in Healthy Subjects and Patients With Muco-Obstructive Lung Disease | ||
| NCT02535416 | A Study of ARC-520 at Varying Infusion Rates in Healthy Adult Volunteers | ||
| NCT05902598 | A Phase 3 Study of ARO-APOC3 / VSA001 / SAR449124 (Plozasiran) in Chinese Adults With Familial Chylomicronemia Syndrome | ||
| NCT02349126 | Study of ARC-520 in Patient With Chronic Hepatitis B Virus | ||
| NCT03362242 | Study of ARO-AAT in Normal Adult Volunteers | ||
| NCT06880770 | Study of Plozasiran in Adults With Severe Hypertriglyceridemia at Risk of Acute Pancreatitis | ||
| NCT05757596 | Study of VSA001 Injection in Chinese Healthy Adult Volunteers | ||
| NCT06796426 | Treatment Protocol of Plozasiran in Adults With High-Risk Severe Hypertriglyceridemia (SHTG) and in Adults and Adolescents With FCS | ||
| NCT04375514 | Study of ARO-ENaC in Healthy Volunteers and in Patients With Cystic Fibrosis | ||
| NCT06347003 | Study of Plozasiran (ARO-APOC3) in Adults With Severe Hypertriglyceridemia | ||
| NCT03945292 | Safety, Tolerability and Pharmacodynamic Effect of Fazirsiran (TAK-999, ARO-AAT) | ||
| NCT06672445 | Study of ARO-ATXN2 Injection in Adults With Spinocerebellar Ataxia Type 2 | ||
| NCT06209177 | Study of ARO-CFB in Adult Healthy Volunteers | ||
| NCT05217667 | Study of ARO-ANG3 in Participants With Homozygous Familial Hypercholesterolemia (HOFH) | ||
| NCT03946449 | Study of Fazirsiran (TAK-999, ARO-AAT) in Patients With Alpha-1 Antitrypsin Deficiency Associated Liver Disease (AATD) | ||
| NCT03747224 | Study of ARO-ANG3 in Healthy Volunteers and in Dyslipidemic Patients | ||
| NCT05949294 | Study of AROSOD-1 in Adult Participants With Amyotrophic Lateral Sclerosis (ALS) | ||
| NCT01872065 | Safety and Tolerability Study of ARC-520 in Healthy Volunteers | ||
| NCT06700538 | A First-In-Human Study of ARO-INHBE in Adults With Obesity With and Without Type 2 Diabetes Mellitus | ||
| NCT05537025 | Study of ARO-MMP7 Inhalation Solution in Healthy Participants and Participants With Idiopathic Pulmonary Fibrosis | ||
| NCT02797522 | A Study of ARC-521 Injection in Normal Adult Volunteers and Patients With Chronic Hepatitis B (CHB) | ||
| NCT02452528 | Study of ARC-520 in Participants With Hepatitis B Virus e Antigen (HBeAg) Positive Chronic Hepatitis B Virus | ||
| NCT03783377 | Study of ARO-APOC3 in Healthy Volunteers, Hypertriglyceridemic Patients and Patients With Familial Chylomicronemia Syndrome (FCS) | ||
| NCT07037771 | A Phase 3 Study of Zodasiran in Adolescent and Adult Subjects With Homozygous Familial Hypercholesterolemia (YOSEMITE) | ||
| NCT07223658 | Study of ARO-DIMERPA in Adult Participants With Mixed Hyperlipidemia | ||
| NCT06937203 | A First-In-Human Study of ARO-ALK7 in Adults With Obesity With and Without Type 2 Diabetes Mellitus |
